Profile data is unavailable for this security.
About the company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, independent delivery networks (IDNs), health plans, employers, consumers, and accountable care organizations (ACOs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provide insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology business, which offers solutions for healthcare providers. The Company’s services are primarily provided under the Quest Diagnostics brand and also provide services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
- Revenue in USD (TTM)9.88bn
- Net income in USD942.00m
- Incorporated1996
- Employees40.00k
- LocationQuest Diagnostics Inc500 Plaza DriveSECAUCUS 07094United StatesUSA
- Phone+1 (973) 520-2700
- Fax+1 (302) 655-5049
- Websitehttps://www.questdiagnostics.com/
Mergers & acquisitions
| Acquired company | DGX:NYQ since announced | Transaction value |
|---|---|---|
| Newyork-Presbyterian Hospital-Laboratory Services Business | -4.25% | -- |
| Northern Light Laboratory | -6.00% | -- |
| LabCare PLUS | 9.34% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corporation | 2.13bn | 249.62m | 7.76bn | 14.17k | 31.42 | 9.67 | 25.14 | 3.64 | 16.53 | 16.53 | 141.39 | 53.70 | 1.53 | 134.43 | 15.44 | 150,699.70 | 17.93 | 20.36 | 22.85 | 25.77 | 35.84 | 33.82 | 11.69 | 12.54 | 0.8827 | 81.93 | 0.1088 | 8.20 | -0.2009 | 5.08 | -7.05 | 22.67 | -2.27 | -- |
| Universal Health Services, Inc. | 13.40bn | 674.86m | 8.64bn | 71.20k | 13.35 | 1.46 | 6.97 | 0.6447 | 9.16 | 9.16 | 181.48 | 83.83 | 1.01 | -- | 7.12 | 188,193.40 | 4.94 | 6.84 | 5.83 | 8.13 | -- | -- | 4.90 | 7.06 | 1.21 | 7.91 | 0.4461 | 5.54 | 5.99 | 5.18 | -31.80 | -1.34 | 4.59 | 14.87 |
| Oak Street Health Inc | 2.16bn | -509.30m | 8.64bn | 3.80k | -- | -- | -- | 4.00 | -2.21 | -2.21 | 9.39 | -1.12 | 1.11 | -- | 2.97 | -- | -26.17 | -30.93 | -45.11 | -55.06 | 3.61 | 3.89 | -23.59 | -24.40 | -- | -184.20 | 1.38 | -- | 50.84 | 63.49 | -24.38 | -- | 47.39 | -- |
| Agilon Health Inc | 2.71bn | -107.02m | 11.48bn | 747.00 | -- | 11.01 | -- | 4.24 | -0.2605 | -0.2594 | 6.55 | 2.52 | 1.65 | -- | 6.85 | 3,625,450.00 | -6.54 | -- | -8.97 | -- | 11.39 | -- | -3.96 | -- | -- | -26.07 | 0.0401 | -- | 47.70 | -- | 73.59 | -- | -- | -- |
| Quest Diagnostics Inc | 9.88bn | 942.00m | 14.95bn | 40.00k | 16.97 | 2.53 | 10.62 | 1.51 | 7.91 | 7.91 | 83.58 | 53.09 | 0.7474 | 32.09 | 7.51 | 247,075.00 | 7.34 | 9.43 | 8.48 | 10.98 | 35.06 | 37.13 | 9.82 | 13.13 | 1.10 | 10.99 | 0.3985 | 24.95 | -8.39 | 5.95 | -52.62 | 7.28 | 9.90 | 7.63 |
| Molina Healthcare Inc | 31.97bn | 792.00m | 15.45bn | 15.00k | 19.57 | 5.19 | 15.96 | 0.4831 | 13.54 | 13.54 | 546.80 | 51.10 | 2.61 | -- | 14.28 | 2,131,600.00 | 6.46 | 7.74 | 14.91 | 17.54 | 15.01 | 16.35 | 2.48 | 3.11 | -- | 13.08 | 0.4465 | 0.00 | 15.13 | 9.97 | 20.18 | -- | 1.14 | -- |
| Laboratory Corp. of America Holdings | 14.88bn | 1.28bn | 19.20bn | 80.00k | 15.68 | 1.90 | 10.03 | 1.29 | 13.84 | 13.84 | 162.32 | 114.47 | 0.7339 | 24.06 | 4.96 | 185,960.00 | 6.32 | 7.49 | 7.39 | 8.72 | 29.48 | 31.52 | 8.61 | 10.27 | 1.35 | 11.17 | 0.3493 | -- | -7.72 | 7.61 | -46.20 | 12.55 | 8.85 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2022 | 13.50m | 12.13% |
| BlackRock Fund Advisorsas of 31 Dec 2022 | 7.30m | 6.56% |
| SSgA Funds Management, Inc.as of 31 Dec 2022 | 5.86m | 5.26% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Dec 2022 | 3.26m | 2.93% |
| Geode Capital Management LLCas of 31 Dec 2022 | 2.36m | 2.12% |
| Dimensional Fund Advisors LPas of 31 Dec 2022 | 2.04m | 1.83% |
| Davis Selected Advisers LPas of 31 Dec 2022 | 1.84m | 1.65% |
| Invesco Capital Management LLCas of 31 Dec 2022 | 1.77m | 1.59% |
| BlackRock Investment Management (UK) Ltd.as of 31 Dec 2022 | 1.69m | 1.52% |
| American Century Investment Management, Inc.as of 31 Dec 2022 | 1.68m | 1.51% |
